ask="4.70"
ask_size="200"
average_daily_volume="117031"
bid="4.00"
bid_size="200"
book_value="1.98"
change="-0.14"
change_from_200_day_moving_average="-0.09"
change_from_50_day_moving_average="0.37"
change_from_52_week_high="-4.00"
change_From_52_week_low="0.93"
change_in_percent="-3.26%"
close="4.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.39"
ebitda="-35.85M"
eps_estimate_current_year="-2.28"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="8580000"
high="4.37"
high_52_weeks="8.15"
last_trade_date="1/18/2017"
last_trade_price="4.15"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.12"
low_52_weeks="3.22"
market_capitalization="77.41M"
moving_average_200_day="4.24"
moving_average_50_day="3.78"
name="Catabasis Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.08%"
percent_change_from_50_day_moving_average="+9.92%"
percent_change_from_52_week_high="-49.08%"
percent_change_from_52_week_low="+28.88%"
previous_close="4.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.17"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18652000"
short_ratio="1.60"
stock_exchange="NGM"
symbol="CATB"
volume="68165"
weeks_range_52="3.22 - 8.15"
